NFKB1 and autoimmune disease: Importantly, while inhibiting macrophage-derived inflammasome function, NAD+ does not interfere with NF-κB signaling which has been shown to promote various inflammatory and autoimmune diseases when dysregulated (Liu et al., 2017).